Interestingly, engineered T cells with a dual-receptor CAR (dCAR-T) exert high cytotoxicity against pancreatic tumor cells expressing tumor antigens, CEA and mesothelin, resulting in 80% apoptosis of tumor cell [96]. Here, MSLN is linked to neoplasm.